Immunohistochemically detectable dickkopf-3 expression in tumor vessels predicts survival in gastric cancer

Virchows Archiv

Volumn 456, Issue 6, 2010, Pages 635-646

  Mühlmann, Gilbert ^a   Untergasser, Gerold ^a   Zitt, Matthias ^a   Zitt, Marion ^b   Maier, Hans ^c   Mikuz, Gregor ^c   Kronberger, Irmgard E ^a   Haffner, Michael C ^a   Gunsilius, Eberhard ^a   Öfner, Dietmar ^d  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^c MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

^d NONE

Author keywords

Dickkopf 3; Gastric cancer; Neoangiogenesis

Indexed keywords

DICKKOPF 3 PROTEIN; GLYCOPROTEIN; UNCLASSIFIED DRUG; DKK3 PROTEIN, HUMAN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; DEMOGRAPHY; DISEASE FREE SURVIVAL; FEMALE; GASTRECTOMY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR CELL; ADENOCARCINOMA; CHEMISTRY; ENDOTHELIUM CELL; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROGNOSIS; STOMACH TUMOR; VASCULARIZATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ENDOTHELIAL CELLS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 77953695520     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00428-010-0926-4     Document Type: Article

References (33)

1. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362:305-315.
2. Van de Velde CJH, Peeters KCMJ (2003) The gastric cancer treatment controversy. J Clin Oncol 21:2234.
3. Cunningham D, Allum WH, Stenning SP et al (2006) Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355:11-20.
4. Earle CC, Maroun JA (1999) Adjuvant chemotherapy after curative resection for gastric cancer in non-asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer 35:1059-1064.
5. Folkman J (1971) Tumor angiogenesis: therapeutic implications. New Engl J Med 285:1182-1186.
6. Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86:353-364.
7. Poon RT, Fan ST, Wong J (2003) Clinical significance of angiogenesis in gastrointestinal cancers: a target for novel prognostic and therapeutic approaches. Ann Surg 238:9-28.
8. St Croix B, Rago C, Velculescu V et al (2000) Genes expressed in human tumor endothelium. Science 289:1197-1202.
9. Krupnik VE, Sharp JD, Jiang C et al (1999) Functional and structural diversity of the human Dickkopf gene family. Gene 238:301-313.
10. Mao B, Wu W, Davidson G et al (2002) Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling. Nature 417:664-667.
11. Niehrs C (2006) Function and biological roles of the Dickkopf family of Wnt modulators. Oncogene 25:7469-7481.
12. Mao B, Niehrs C (2003) Kremen2 modulates Dickkopf2 activity during Wnt/LRP6 signaling. Gene 302:179-183.
13. Kawano Y, Kitaoka M, Hamada Y et al (2006) Regulation of prostate cell growth and morphogenesis by Dickkopf-3. Oncogene 25:6528-6537.
14. Kobayashi K, Ouchida M, Tsuji T et al (2002) Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells. Gene 282:151-158.
15. Kurose K, Sakaguchi M, Nasu Y et al (2004) Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma. J Urol 171:1314-1318.
16. Lodygin D, Epanchintsev A, Menssen A et al (2005) Functional epigenomics identifies genes frequently silenced in prostate cancer. Cancer Res 65:4218-4227.
17. Nozaki I, Tsuji T, Iijima O et al (2001) Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer. Int J Oncol 19:117-121.
18. Roman-Gomez J, Jimenez-Velasco A, Agirre X et al (2004) Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia. Br J Cancer 91:707-713.
19. Tsuji T, Miyazaki M, Sakaguchi M et al (2000) A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines. Biochem Biophys Res Commun 268:20-24.
20. Zitt M, Untergasser G, Amberger A et al (2008) Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: expression in cancer tissue and adjacent non-cancerous tissue. Dis Markers 24(2):101-109.
21. Untergasser G, Steurer M, Zimmermann M et al (2008) The Dickkopf-homolog 3 is expressed in tumor endothelial cells and supports capillary formation. Int J Cancer 122:1539-1547.
22. Sobin LH (2009) TNM classification of malignant tumours. Wiley, New York.
23. WHO (2000) Classification of Tumors. Pathology and Genetics of Tumors of Digestive System. IARC, Lyon.
24. Macdonald JS, Smalley SR, Benedetti J et al (2001) Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345:725-730.
25. Weidner N, Semple JP, Welch WR et al (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
26. Gastl G, Spizzo G, Obrist P et al (2000) Ep-CAM overexpression in breast cancer as a predictor of survival. Lancet 356:1981-1982.
27. Zhao H-C, Qin R, Chen X-X et al (2006) Microvessel density is a prognostic marker of human gastric cancer. World J Gastroenterol 21:2598-2603.
28. Araya M, Terashima M, Takagane A et al (1997) Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol 65:232-236.
29. Li Y, Ye X, Tan C et al (2009) Axl as a potential therapeutic target in cancer: role of Axl in tumor growth, metastasis and angiogenesis. Oncogene 28:3442-3455.
30. Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8:579-591.
31. Fong D, Hermann M, Untergasser G et al (2009) Dkk-3 expression in the tumor endothelium: a novel prognostic marker of pancreatic adenocarcinomas. Cancer Sci 100:1414-1420.
32. Kuphal S, Lodermeyer S, Bataille F et al (2006) Expression of Dickkopf genes is strongly reduced in malignant melanoma. Oncogene 25:5027-5036.
33. Yu J, Tao Q, Cheng YY et al (2009) Promoter methylation of the Wnt/beta-catenin signaling antagonist Dkk-3 is associated with poor survival in gastric cancer. Cancer 115(1):49-60.